Researchers have identified how the body's own immune system contributes to the nerve fiber damage caused by multiple sclerosis, a finding that can potentially aid earlier diagnosis and improved treatment for this chronic disease. The stud...

Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late stage biotechnology company focused on commercializing its proprietary cellular energy regulation technology, announced today that patient enrollment for the first stage of its Phase I...

In a finding that may provide a scientific basis for eventual treatment, neurology researchers have shown that traumatic brain injury reduces the level of a protein that helps keep brain activity in balance. The resulting abnormal activity...

Ceregene, Inc., announced today that CERE-120, a gene therapy product in development for the treatment of Parkinson's disease, was well tolerated and appeared to reduce symptoms by approximately 40% (p The study was authored by: Dr. Jill O...

A novel look at the brains of adults with autism has provided evidence that various brain regions of people with the developmental disorder may not communicate with each other as efficiently as they do in other people. Researchers from...

People addicted to cocaine have an impaired ability to perceive rewards and exercise control due to disruptions in the brain's reward and control circuits, according to a series of brain-mapping studies and neuropsychological tests conduct...

The neurotransmitter dopamine continues to be released for nearly an hour after neurons are stimulated, suggesting the existence of secondary mechanisms that allow for sustained availability of dopamine in different regions of the brain in...

A team of scientists at the Medical University of South Carolina (MUSC) has found evidence that further links high cholesterol levels to Alzheimer's disease. The research, led by MUSC neuroscientist, Narayan R. Bhat, Ph.D., further support...

Brain research had a boost on 14 October as CSIRO launched in the United States its HCA-Vision nerve cell analysis software at Neuroscience 2006 in Atlanta, Georgia, the world's largest conference for brain researchers. HCA-Vision is based...

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the presentation of preclinical data from its ZFP Therapeutic(TM) program in nerve regeneration at the 2006 Annual Meeting of The Society for Neuroscience. The meeting is being held...